78
ECP 2014 ·
London
Poster Presentations
a
Sunday
Sunday, 31 Aug
PS-03
015
Pleomorphic adenoma (benign mixed
tumour) of the breast in the background
of intraductal papilloma
Esra Canan Kelten,
Turkey
C. Boyaci, C. Leblebici, K. Behzatoglu,
S. Sirin, G. Erdem Huq, M. A. Nazli, S. Aksoy,
E. R. Bozkurt
016
Determining the optimal breast specimen
sampling method for the assessment of
the incidence of multiple breast carcinoma
Denisa Georgiana Moncea,
Romania
I. Barsan, R. Georgescu, M. D. Podeanu,
C. Moldovan, M. Boros, S. Stolnicu
017
The nuclear grade plus proliferation grad-
ing system for Invasive Ductal Carcinoma
of the breast: Validation in a tertiary refer-
ral hospital cohort in a white Caucasian
population
Maria Papadimitriou,
Greece
S. Kaptanis, E. Polymeropoulos,
G. Mitsopoulos, D. Stogiannis, C. Caroni,
G. Apostolou, G. Vaiopoulos,
J. G. Panayiotides, P. Karakitsos
018
Ki-67 expression in sclerosing adenosis
(SA) and adjacent normal breast terminal
ductal lobular units (TDLUs): A nested
case/control study from the Mayo Benign
Breast Disease (BBD) Cohort
Aziza Nassar,
USA
A. Degnim, M. Frost, R. Vierkant, T. Hoskin,
L. Hartmann, D. Radisky, D. Visscher
019
Digistain: A new objective method for
grading breast carcinoma using routinely
processed paraffin sections
Hemmel Amrania,
United Kingdom
L. Drummond, L. Woodley, C. Phillips,
S. Shousha, C. Coombes
020
Large-sections in breast pathology: Pre-
liminary report of single institution experi-
ence
Jasminka Jakic-Razumovic,
Croatia
I. Brcic, D. Tentor, P. Podolski, M. Prutki,
D. Vrbanec, D. Mijatovic
021
Primary breast angiosarcoma: A rare entity
Samir Miladi,
Tunisia
A. Guebsi, W. Jomaa, I. Bettaieb, O. Lamine,
O. Gammoudi, A. El-May
022
Triple Negative Breast Cancer (TNBC):
Experience of the Institut National
d’Oncologie of Rabat about 87 cases
Mariam Amrani,
Morocco
H. Hachlef, R. Elochi, H. Elouazzani, N. Tazi
023
The prognostic and predictive significance
of PARP-1 in locally advanced breast can-
cer patients receiving neoadjuvant chemo-
therapy
Hayam Abdel Samie Aiad,
Egypt
M. Kandil, M. El-Tahmody, I. Abulkheir,
F. Abulkasem, A. Elmansori, M. Aleskandarany
024
Immunohistochemical analysis of the
PTEN-and Muc4-associated Her2/neu of
breast cancer resistance to trastuzumab
Galina Khamidullina,
Kazakhstan
E. Sereda, N. Zharkov
025
Sentinel node handling and reporting in
Kent: A re-audit
Lorna Donovan,
United Kingdom
R. Liebmann, G. Russell
026
Nipple discharge and pathological findings
Petr Vážan,
Czech Republic
027
Activated c-Jun is a luminal-related marker
associated with better outcome in breast
cancer
Dena Jerjees,
United Kingdom
R. Abduljabbar, A. Muftah, C. Nolan,
A. Green, I. Ellis, E. Rakha
028
p38 MAPK is a marker of good prognosis
in breast cancer and is an independent
predictor of better outcome in the luminal
class
Dena Jerjees,
United Kingdom
R. Abduljabbar, M. Al-Kaabi, C. Nolan,
A. Green, I. Ellis, E. Rakha
